Literature DB >> 19339698

Sustained high-level polyclonal hematopoietic marking and transgene expression 4 years after autologous transplantation of rhesus macaques with SIV lentiviral vector-transduced CD34+ cells.

Yoo-Jin Kim1, Yoon-Sang Kim, Andre Larochelle, Gabriel Renaud, Tyra G Wolfsberg, Rima Adler, Robert E Donahue, Peiman Hematti, Bum-Kee Hong, Jean Roayaei, Keiko Akagi, Janice M Riberdy, Arthur W Nienhuis, Cynthia E Dunbar, Derek A Persons.   

Abstract

We previously reported that lentiviral vectors derived from the simian immunodeficiency virus (SIV) were efficient at transducing rhesus hematopoietic repopulating cells. To evaluate the persistence of vector-containing and -expressing cells long term, and the safety implications of SIV lentiviral vector-mediated gene transfer, we followed 3 rhesus macaques for more than 4 years after transplantation with transduced CD34+ cells. All 3 animals demonstrated significant vector marking and expression of the GFP transgene in T cells, B cells, and granulocytes, with mean GFP+ levels of 6.7% (range, 3.3%-13.0%), 7.4% (4.2%-13.4%), and 5.6% (3.1%-10.5%), respectively. There was no vector silencing in hematopoietic cells over time. Vector insertion site analysis of granulocytes demonstrated sustained highly polyclonal reconstitution, with no evidence for progression to oligoclonality. A significant number of clones were found to contribute at both 1-year and 3- or 4-year time points. No vector integrations were detected in the MDS1/EVI1 region, in contrast to our previous findings with a gamma-retroviral vector. These data show that lentiviral vectors can mediate stable and efficient long-term expression in the progeny of transduced hematopoietic stem cells, with an integration profile that may be safer than that of standard Moloney murine leukemia virus (MLV)-derived retroviral vectors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339698      PMCID: PMC2689045          DOI: 10.1182/blood-2008-10-185199

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  61 in total

Review 1.  Gene therapy for the hemoglobin disorders: past, present, and future.

Authors:  D A Persons; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  PACS-1 binding to adaptors is required for acidic cluster motif-mediated protein traffic.

Authors:  C M Crump; Y Xiang; L Thomas; F Gu; C Austin; S A Tooze; G Thomas
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

3.  Recurrent retroviral vector integration at the Mds1/Evi1 locus in nonhuman primate hematopoietic cells.

Authors:  Boris Calmels; Cole Ferguson; Mikko O Laukkanen; Rima Adler; Marion Faulhaber; Hyeoung-Joon Kim; Stephanie Sellers; Peiman Hematti; Manfred Schmidt; Christof von Kalle; Keiko Akagi; Robert E Donahue; Cynthia E Dunbar
Journal:  Blood       Date:  2005-06-02       Impact factor: 22.113

4.  Marking and gene expression by a lentivirus vector in transplanted human and nonhuman primate CD34(+) cells.

Authors:  D S An; R P Wersto; B A Agricola; M E Metzger; S Lu; R G Amado; I S Chen; R E Donahue
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group.

Authors:  H J Kolb; G Socié; T Duell; M T Van Lint; A Tichelli; J F Apperley; E Nekolla; P Ljungman; N Jacobsen; M van Weel; R Wick; M Weiss; H G Prentice
Journal:  Ann Intern Med       Date:  1999-11-16       Impact factor: 25.391

6.  Lentivirus vector-mediated hematopoietic stem cell gene transfer of common gamma-chain cytokine receptor in rhesus macaques.

Authors:  D S An; S K Kung; A Bonifacino; R P Wersto; M E Metzger; B A Agricola; S H Mao; I S Chen; R E Donahue
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

7.  Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.

Authors:  M Cavazzana-Calvo; S Hacein-Bey; G de Saint Basile; F Gross; E Yvon; P Nusbaum; F Selz; C Hue; S Certain; J L Casanova; P Bousso; F L Deist; A Fischer
Journal:  Science       Date:  2000-04-28       Impact factor: 47.728

8.  Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin.

Authors:  C May; S Rivella; J Callegari; G Heller; K M Gaensler; L Luzzatto; M Sadelain
Journal:  Nature       Date:  2000-07-06       Impact factor: 49.962

9.  Functional requirements for phenotypic correction of murine beta-thalassemia: implications for human gene therapy.

Authors:  D A Persons; E R Allay; D E Sabatino; P Kelly; D M Bodine; A W Nienhuis
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

10.  Hot spots of retroviral integration in human CD34+ hematopoietic cells.

Authors:  Claudia Cattoglio; Giulia Facchini; Daniela Sartori; Antonella Antonelli; Annarita Miccio; Barbara Cassani; Manfred Schmidt; Christof von Kalle; Steve Howe; Adrian J Thrasher; Alessandro Aiuti; Giuliana Ferrari; Alessandra Recchia; Fulvio Mavilio
Journal:  Blood       Date:  2007-05-16       Impact factor: 22.113

View more
  36 in total

1.  Gene therapy for canine leukocyte adhesion deficiency with lentiviral vectors using the murine stem cell virus and human phosphoglycerate kinase promoters.

Authors:  Michael J Hunter; Huifen Zhao; Laura M Tuschong; Thomas R Bauer; Tanya H Burkholder; Derek A Persons; Dennis D Hickstein
Journal:  Hum Gene Ther       Date:  2011-04-11       Impact factor: 5.695

Review 2.  Hematopoietic stem cell engineering at a crossroads.

Authors:  Isabelle Rivière; Cynthia E Dunbar; Michel Sadelain
Journal:  Blood       Date:  2011-11-17       Impact factor: 22.113

3.  Nonmyeloablative conditioning regimen to increase engraftment of gene-modified hematopoietic stem cells in young rhesus monkeys.

Authors:  Alice F Tarantal; Francesca Giannoni; C Chang I Lee; Jennifer Wherley; Teiko Sumiyoshi; Michele Martinez; Christoph A Kahl; David Elashoff; Stan G Louie; Donald B Kohn
Journal:  Mol Ther       Date:  2012-01-31       Impact factor: 11.454

4.  Counting stem cells: methodological constraints.

Authors:  Leonid V Bystrykh; Evgenia Verovskaya; Erik Zwart; Mathilde Broekhuis; Gerald de Haan
Journal:  Nat Methods       Date:  2012-05-30       Impact factor: 28.547

5.  Transduction of human primitive repopulating hematopoietic cells with lentiviral vectors pseudotyped with various envelope proteins.

Authors:  Yoon-Sang Kim; Matthew M Wielgosz; Phillip Hargrove; Steven Kepes; John Gray; Derek A Persons; Arthur W Nienhuis
Journal:  Mol Ther       Date:  2010-04-06       Impact factor: 11.454

6.  Quantitative stability of hematopoietic stem and progenitor cell clonal output in rhesus macaques receiving transplants.

Authors:  Samson J Koelle; Diego A Espinoza; Chuanfeng Wu; Jason Xu; Rong Lu; Brian Li; Robert E Donahue; Cynthia E Dunbar
Journal:  Blood       Date:  2017-01-13       Impact factor: 22.113

7.  Future alternative therapies for β-thalassemia.

Authors:  Stefano Rivella; Eliezer Rachmilewitz
Journal:  Expert Rev Hematol       Date:  2009-12-01       Impact factor: 2.929

Review 8.  Hematopoietic stem cell gene therapy:assessing the relevance of preclinical models.

Authors:  Andre Larochelle; Cynthia E Dunbar
Journal:  Semin Hematol       Date:  2013-04       Impact factor: 3.851

9.  Gene therapy activates EVI1, destabilizes chromosomes.

Authors:  Cynthia E Dunbar; Andre Larochelle
Journal:  Nat Med       Date:  2010-02       Impact factor: 53.440

10.  RGB marking facilitates multicolor clonal cell tracking.

Authors:  Kristoffer Weber; Michael Thomaschewski; Michael Warlich; Tassilo Volz; Kerstin Cornils; Birte Niebuhr; Maike Täger; Marc Lütgehetmann; Jörg-Matthias Pollok; Carol Stocking; Maura Dandri; Daniel Benten; Boris Fehse
Journal:  Nat Med       Date:  2011-03-27       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.